Vaccination Reaction
10
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
CARD for Community Pharmacy Vaccinations - Phase 2
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients
Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine
Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration of a Non-public Marketed Vaccine in the General Population, Real-life Study
CARD for Community Pharmacy Vaccinations
Hepatitis B Vaccination After Neonatal Surgery
Early Antibiotic Therapy and Vaccinations in Preterm Infants
Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination
Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.
Early Antibiotic Therapy and Vaccination